Statistics From Daisycon Are Available Now In The Affiliate

Publisher can check now your statistics from the affiliate network by Daisycon in the affiliate dashboard. The affiliate dashboard is a tool go specifically designed new media GmbH & co. KG by the company for publishers. The tool summarizes all statistics from various affiliate networks clearly in an overview. Speaking candidly GSK told us the story. In this way, your total earnings can see a Publisher without much effort. Tedious and time-consuming log in the different networks, to control revenues, will lapse with the tool.

Clear presentation of all statistical data many affiliate networks, including now also Daisycon, supported already connect to the dashboard. Publisher can themselves determine what networks you want to see the statistics. The data can be either cumulative or displayed per network. The program provides not only an overview of the revenues, but provides users in many analysis options to optimize for various comparisons available. So the statistics of individual affiliate programs can be seen a, for example, by using a program analysis, the Publisher advertises.

The tool is suitable for traveling very well to control commissions. Therefore a mobile version is also available. The data supplied in like in the network by Daisycon themselves in real time. The results are displayed in tabular form and using clear diagrams. Also can receive Publisher daily or weekly a report as a PDF document by E-Mail applied according to individual wishes. Optionally, also an alert using the alert feature is adjustable, which notifies the Publisher via E-Mail at an under – or exceeding certain values. Data security even on the issue of data security has been thought in the development of the affiliate dashboard. The Web page has a GeoTrust authentication and encrypts all access data storage. Data will not be disclosed to third parties and will be at the termination of the Subscriptions are completely erased. Free subscription Publisher to try the dashboard for a trial period of 7 days.